Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
4.680
+0.820 (21.24%)
Nov 21, 2024, 10:43 AM EST - Market open
Biodexa Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 3 | 7 | 4 | 13 | 24 | 16 | |
| Market Cap Growth | 194.10% | 64.68% | -67.88% | -43.67% | 46.08% | 246.87% | |
| Enterprise Value | -4 | 1 | -3 | 9 | 23 | 6 | |
| Last Close Price | 3.85 | 67.00 | 7880.00 | 42000.00 | 74800.00 | 137860.00 | |
| PS Ratio | 7.00 | 14.47 | 5.06 | 16.96 | 50.31 | 18.07 | |
| PB Ratio | 0.13 | 1.18 | 1.12 | 0.94 | 2.57 | 0.62 | |
| P/TBV Ratio | 2.51 | 3.17 | 1.12 | 0.94 | 2.57 | 1.70 | |
| EV/Sales Ratio | 15.39 | 2.20 | - | 10.97 | 48.15 | 6.85 | |
| Debt / Equity Ratio | 0.04 | 0.10 | 0.20 | 0.07 | 0.04 | 0.31 | |
| Asset Turnover | 0.01 | 0.05 | 0.08 | 0.05 | 0.02 | 0.03 | |
| Quick Ratio | 2.16 | 1.20 | 2.27 | 6.06 | 3.02 | 2.40 | |
| Current Ratio | 2.16 | 1.26 | 2.47 | 6.39 | 3.10 | 2.42 | |
| Return on Equity (ROE) | -97.23% | -180.59% | -112.47% | -63.60% | -168.89% | -50.10% | |
| Return on Assets (ROA) | -37.52% | -51.38% | -51.33% | -38.48% | -32.76% | -27.56% | |
| Return on Capital (ROIC) | -55.03% | -92.46% | -63.08% | -48.07% | -40.89% | -32.29% | |
| Earnings Yield | -385.37% | -128.44% | -216.38% | -55.70% | -128.57% | -82.81% | |
| FCF Yield | -439.96% | -124.32% | -200.95% | -64.56% | -55.11% | -55.83% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.